Purpose: base award for in vitro metabolism and metabolite quantification period of performance: 07/06/2015 - 07/05/2020
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201500018C
- Awardee
-
Xenotech LLC UEI MAQKL1MN66A9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $403,276
Award facts
- Opportunity
-
- HHSN271201500018C Solicitation number
- InVitro Metabolism and Metabolite Quantification Award Notice · Posted Apr 28, 2014
- Contract value 29% obligated
-
- $403,276.30 Current, with exercised options
- $1,391,921.30 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rosedale, KS 66103, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$71,919 | |
| Other Administrative Action | -$21,603 | |
| Funding Only Action | $23,973 | |
| Funding Only Action | $47,946 | |
| Other Administrative Action | $74,732 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $29,040 | |
| Funding Only Action | $35,020 | |
| Funding Only Action | $74,732 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$8,136 | |
| Vendor Address Change | $0 | |
| Funding Only Action | $64,503 | |
| Funding Only Action | $115,033 | |
| Funding Only Action | $23,973 | |
| Original award | $15,982 |
Show all 17
About this award
This is a firm fixed price contract awarded by the National Institute on Drug Abuse (NIDA), an agency of the U.S. Department of Health and Human Services, to Xenotech LLC, doing business as Sekisui-Xenotech, for in vitro metabolism and metabolite quantification services. The period of performance is from July 6, 2015 to July 5, 2020, with a ceiling value of $1,391,921.30. This contract is not set aside for any specific business category. Xenotech, a small disadvantaged business, specializes in providing biomedical research materials and services, particularly in the areas of drug metabolism and drug-drug interaction studies to support federal research and development programs. The contract award references a previous modification to de-obligate $21,602.70 from expiring fiscal year 2016 funds under Task Order 004.
Quick answers
Who was awarded contract HHSN271201500018C?
HHSN271201500018C was awarded to Xenotech LLC by National Institute on Drug Abuse (National Institutes of Health) on July 6, 2015.
How much is contract HHSN271201500018C worth?
The government has obligated $403,276 on HHSN271201500018C. Its potential value, with all options, is $1,391,921.
Was contract HHSN271201500018C competed?
The extent of competition for HHSN271201500018C was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award